1. Higher triglyceride level predicts hyperuricemia: A prospective study of 6-year follow-up 
Yuan Zhang, Fengjiang Wei, PhD, Chen Chen, MD, Chunyou Cai, PhD, Kai Zhang, MD, Ning Sun, MD, Jianli Tian, MD, Wentao Shi, PhD, Miaomiao Zhang, Yong Zang, Jiani Song, Yukun He, Jiayi Feng, Qianqian Zhou, Mengyan Li, Pufei Bai, Shuzhi Feng, MD, Wei- Dong Li, MD, PhD 
Journal of Clinical Lipidology 
Volume 12, Issue 1, Pages (January 2018)
DOI: /j.jacl
Copyright © 2017 National Lipid Association Terms and Conditions

2. Figure 1 Flow chart of subject selection for the present study.
Journal of Clinical Lipidology  , DOI: ( /j.jacl )
Copyright © 2017 National Lipid Association Terms and Conditions

3. Figure 2
Cumulative prevalence of hyperuricemia, by baseline triglyceride quartile: quartile 1, <0.94 mmol/L; quartile 2, 0.94–1.30 mmol/L; quartile 3, 1.31–1.85 mmol/L; quartile 4, >1.85 mmol/L.
Journal of Clinical Lipidology  , DOI: ( /j.jacl )
Copyright © 2017 National Lipid Association Terms and Conditions

4. Figure 3
Kaplan–Meier curves for hyperuricemia by triglyceride quartile: first quartile, <0.94 mmol/L (<P25); second quartile, 0.94–1.30 mmol/L(P25∼); third quartile, 1.31–1.85 mmol/L(P50∼); and fourth quartile, >1.85 mmol/L (≥P75). P value < .01 for log-rank test, first quartile vs other quartiles.
Journal of Clinical Lipidology  , DOI: ( /j.jacl )
Copyright © 2017 National Lipid Association Terms and Conditions

5. Figure 4
Adjusted hazard ratios (95% confidence intervals) for incidence of hyperuricemia stratified by sex, body mass index, age, estimated glomerular filtration rate (eGFR), and history of hypertension.
Journal of Clinical Lipidology  , DOI: ( /j.jacl )
Copyright © 2017 National Lipid Association Terms and Conditions